Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Closed
Phase 3
This study is looking at pembrolizumab and epacadostat as the first treatment for non small cell lung cancer that has spread elsewhere in the body.
Recruitment start: 7 February 2018
Recruitment end: 31 July 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Katy Clarke
Merck Sharp & Dohme Ltd
Last reviewed: 30 July 2018
CRUK internal database number: 15426
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
